Search research articles
Contact Us
Filters
Showing results (41-50 of 96) with videos related to
Page
of 10
Sort By:
Archivos Espanoles De Urologia
|
June 16, 2020
Renal cell carcinoma and COVID-19 pandemia: Management strategies adapted to current practice
Vital Hevia, Estefanía Linares-Espinós, Teresa Alonso-Gordoa, et al.
European Urology Focus
|
February 23, 2022
Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors
Matteo Santoni, Francesco Massari, Sergio Bracarda, et al.
Cancers
|
March 14, 2019
Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs
Elisa Conde Moreno, Alejandro Pascual, Daniel Prieto-Cuadra, et al.
Clinical Genitourinary Cancer
|
March 20, 2022
Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison
Matteo Santoni, Gaetano Aurilio, Francesco Massari, et al.
Translational Lung Cancer Research
|
August 12, 2022
Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report
Javier Pozas, Víctor Albarrán-Fernández, Luis González-Campo, et al.
Biochemistry and Biophysics Reports
|
August 18, 2025
mRNA expression, tumor heterogeneity, and response to therapy in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1α)
Cristina Aguzzi, Simona De Summa, Javier Molina-Cerrillo, et al.
The Oncologist
|
June 30, 2021
Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial
Enrique Grande, Cristina Rodriguez-Antona, Carlos López, et al.
The Oncologist
|
February 12, 2020
The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407)
Enrique Grande, Alex Teulé, Teresa Alonso-Gordoa, et al.
Targeted Oncology
|
August 2, 2021
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study
Matteo Santoni, Francesco Massari, Enrique Grande, et al.
Expert Opinion on Pharmacotherapy
|
February 4, 2026
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group
Concetta Calabrò, Francesco Ciccimarra, Alessandro Rizzo, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 96) with videos related to
Sort By:
Page
of 10
Archivos Espanoles De Urologia
|
June 16, 2020
Renal cell carcinoma and COVID-19 pandemia: Management strategies adapted to current practice
Vital Hevia, Estefanía Linares-Espinós, Teresa Alonso-Gordoa, et al.
European Urology Focus
|
February 23, 2022
Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors
Matteo Santoni, Francesco Massari, Sergio Bracarda, et al.
Cancers
|
March 14, 2019
Novel Molecular Characterization of Colorectal Primary Tumors Based on miRNAs
Elisa Conde Moreno, Alejandro Pascual, Daniel Prieto-Cuadra, et al.
Clinical Genitourinary Cancer
|
March 20, 2022
Nivolumab VERSUS Cabozantinib as Second-Line Therapy in Patients With Advanced Renal Cell Carcinoma: A Real-World Comparison
Matteo Santoni, Gaetano Aurilio, Francesco Massari, et al.
Translational Lung Cancer Research
|
August 12, 2022
Anti-Zic4 paraneoplastic cerebellar degeneration in a patient with EGFR-mutated NSCLC: a case report
Javier Pozas, Víctor Albarrán-Fernández, Luis González-Campo, et al.
Biochemistry and Biophysics Reports
|
August 18, 2025
mRNA expression, tumor heterogeneity, and response to therapy in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1α)
Cristina Aguzzi, Simona De Summa, Javier Molina-Cerrillo, et al.
The Oncologist
|
June 30, 2021
Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial
Enrique Grande, Cristina Rodriguez-Antona, Carlos López, et al.
The Oncologist
|
February 12, 2020
The PALBONET Trial: A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407)
Enrique Grande, Alex Teulé, Teresa Alonso-Gordoa, et al.
Targeted Oncology
|
August 2, 2021
Cabozantinib in Pretreated Patients with Metastatic Renal Cell Carcinoma with Sarcomatoid Differentiation: A Real-World Study
Matteo Santoni, Francesco Massari, Enrique Grande, et al.
Expert Opinion on Pharmacotherapy
|
February 4, 2026
Belzutifan monotherapy and combination therapies in renal cell carcinoma: a clinical trial perspective from the ARON working group
Concetta Calabrò, Francesco Ciccimarra, Alessandro Rizzo, et al.
Page
of 10